Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2009-5-15
pubmed:abstractText
Although aspirin treatment is useful in reducing ischaemic events in diabetic patients, recent studies suggest that it is less effective when compared with non-diabetics (ND). We sought to evaluate COX-1 sensitivity and thromboxane A(2) (TxA(2)) production in type 1 (T1DM) and type 2 diabetic (T2DM) patients under chronic aspirin treatment, and also evaluate the association between thromboxane A(2) (TxA(2)) production and markers of inflammation and metabolic control, such as high-sensitivity C-reactive protein, fasting blood glucose, and haemoglobin A1c (HbA1c).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1522-9645
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1279-86
pubmed:meshHeading
pubmed-meshheading:19346231-Adult, pubmed-meshheading:19346231-Aged, pubmed-meshheading:19346231-Aspirin, pubmed-meshheading:19346231-Blood Platelets, pubmed-meshheading:19346231-C-Reactive Protein, pubmed-meshheading:19346231-Case-Control Studies, pubmed-meshheading:19346231-Cyclooxygenase 1, pubmed-meshheading:19346231-Diabetes Mellitus, Type 1, pubmed-meshheading:19346231-Diabetes Mellitus, Type 2, pubmed-meshheading:19346231-Diabetic Angiopathies, pubmed-meshheading:19346231-Drug Resistance, pubmed-meshheading:19346231-Female, pubmed-meshheading:19346231-Hemoglobin A, Glycosylated, pubmed-meshheading:19346231-Humans, pubmed-meshheading:19346231-Hyperglycemia, pubmed-meshheading:19346231-Male, pubmed-meshheading:19346231-Middle Aged, pubmed-meshheading:19346231-Platelet Aggregation, pubmed-meshheading:19346231-Platelet Aggregation Inhibitors, pubmed-meshheading:19346231-Statistics, Nonparametric, pubmed-meshheading:19346231-Thromboxane A2
pubmed:year
2009
pubmed:articleTitle
COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.
pubmed:affiliation
Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy. fabio.pulcinelli@uniroma1.it
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't